The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ESPERION THERAPEUTICS INC NE COMMON 29664W105 47,028 1,200,000 SH   DFND 1 0 0 1,200,000
ESPERION THERAPEUTICS INC NE COMMON 29664W105 4 100 SH   DFND   0 0 100
INSEEGO CORP NOTE 5.500% 6/1 45782BAA2 255,053 13,700,000 PRN   DFND   0 0 13,700,000
MACROGENICS INC. COMMON 556099109 20,184 977,426 SH   DFND 1 0 0 977,426
MEDICINES CO COMMON 584688105 25,816 703,440 SH   DFND 1 0 0 703,440
MEDICINES CO COMMON 584688105 112,860 3,075,202 SH   DFND 2 0 0 3,075,202
MEDICINES CO COMMON 584688105 4 100 SH   DFND   0 0 100
MIRATI THERAPEUTICS INC COMMON 60468T105 154,603 3,135,966 SH   DFND 1 0 0 3,135,966
SOLID BIOSCIENCES INC. COMMON 83422E105 409 11,488 SH   DFND 1 0 0 11,488